Torabi, Asad J.Villegas-Galaviz, JosueGuglin, MayaFrick, KyleRao, Roopa2021-04-142021-04-142020Torabi, A. J., Villegas-Galaviz, J., Guglin, M., Frick, K., & Rao, R. (2020). Cardiogenic shock following cardiac tamponade and Takotsubo in COVID-19. Future Cardiology. https://doi.org/10.2217/fca-2020-0115https://hdl.handle.net/1805/25636This article is made available for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.Introduction: Takotsubo is often described as stress-induced cardiomyopathy and is a known cause of heart failure. Objective: Review the clinical course of a young coronavirus disease 2019 (COVID-19) patient who developed Takotsubo following cardiac tamponade. Case presentation: A 42-year-old woman presented to the emergency department with fever, altered mental status and hypoxia. She was ultimately found to be in cardiac tamponade and within 2 hours of a pericardiocentesis she developed Takotsubo and was in cardiogenic shock. Her family decided to place her on comfort measures and she died the same day. Discussion: This case illustrates the increasing number of cardiovascular complications being reported in COVID-19 and highlights the importance of clinicians to be aware of these challenges. Conclusion: Here, we report a distinct presentation of cardiogenic shock in a young COVID-19 patient. The rapid onset of her suspected Takotsubo and the severity of her disease were striking features in this case.enPublic Health Emergencycardiac tamponadecardiogenic shockCOVID-19Report